314 related articles for article (PubMed ID: 30877677)
1. Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays.
Lucidarme J; Louth J; Townsend-Payne K; Borrow R
Methods Mol Biol; 2019; 1969():169-179. PubMed ID: 30877677
[TBL] [Abstract][Full Text] [Related]
2. Serum bactericidal antibody assays - The role of complement in infection and immunity.
McIntosh ED; Bröker M; Wassil J; Welsch JA; Borrow R
Vaccine; 2015 Aug; 33(36):4414-21. PubMed ID: 26187262
[TBL] [Abstract][Full Text] [Related]
3. Use of expanded
Borrow R; Martinón-Torres F; Abitbol V; Andani A; Preiss S; Muzzi A; Serino L; Sohn WY
Expert Rev Vaccines; 2023; 22(1):738-748. PubMed ID: 37622470
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
[TBL] [Abstract][Full Text] [Related]
5. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
[TBL] [Abstract][Full Text] [Related]
6. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.
Maslanka SE; Gheesling LL; Libutti DE; Donaldson KB; Harakeh HS; Dykes JK; Arhin FF; Devi SJ; Frasch CE; Huang JC; Kriz-Kuzemenska P; Lemmon RD; Lorange M; Peeters CC; Quataert S; Tai JY; Carlone GM
Clin Diagn Lab Immunol; 1997 Mar; 4(2):156-67. PubMed ID: 9067649
[TBL] [Abstract][Full Text] [Related]
7. Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines.
Sikkema DJ; Friedman KE; Corsaro B; Kimura A; Hildreth SW; Madore DV; Quataert SA
Clin Diagn Lab Immunol; 2000 Sep; 7(5):764-8. PubMed ID: 10973451
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
[TBL] [Abstract][Full Text] [Related]
9. Meningococcal surrogates of protection--serum bactericidal antibody activity.
Borrow R; Balmer P; Miller E
Vaccine; 2005 Mar; 23(17-18):2222-7. PubMed ID: 15755600
[TBL] [Abstract][Full Text] [Related]
10. A glycoconjugate vaccine for Neisseria meningitidis induces antibodies in human infants that afford protection against meningococcal bacteremia in a neonate rat challenge model.
Mountzouros KT; Belanger KA; Howell AP; Bixler GS; Madore DV
Infect Immun; 2002 Dec; 70(12):6576-82. PubMed ID: 12438327
[TBL] [Abstract][Full Text] [Related]
11. Understanding immunogenicity assessments for meningococcal serogroup B vaccines.
Balmer P; Beeslaar J; Findlow J; Srivastava A
Postgrad Med; 2020 Mar; 132(2):184-191. PubMed ID: 32124678
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease.
Frasch CE; Borrow R; Donnelly J
Vaccine; 2009 Jun; 27 Suppl 2():B112-6. PubMed ID: 19464093
[TBL] [Abstract][Full Text] [Related]
13. Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies.
Brodszki N; Skattum L; Bai X; Findlow H; Borrow R; Jönsson G
Vaccine; 2015 Apr; 33(15):1839-45. PubMed ID: 25707694
[TBL] [Abstract][Full Text] [Related]
14. In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway.
Ispasanie E; Muri L; Schmid M; Schubart A; Thorburn C; Zamurovic N; Holbro T; Kammüller M; Pluschke G
Front Immunol; 2023; 14():1180833. PubMed ID: 37457736
[TBL] [Abstract][Full Text] [Related]
15. A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines.
Findlow J; Balmer P; Borrow R
Hum Vaccin Immunother; 2019; 15(10):2491-2500. PubMed ID: 30883271
[TBL] [Abstract][Full Text] [Related]
16. Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial.
Marshall HS; Richmond PC; Beeslaar J; Jiang Q; Jansen KU; Garcés-Sánchez M; Martinón-Torres F; Szenborn L; Wysocki J; Eiden J; Harris SL; Jones TR; Lee SS; Perez JL;
Lancet Infect Dis; 2017 Jan; 17(1):58-67. PubMed ID: 27745812
[TBL] [Abstract][Full Text] [Related]
17. Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.
Joseph H; Balmer P; Bybel M; Papa T; Ryall R; Borrow R
Clin Diagn Lab Immunol; 2004 Jan; 11(1):1-5. PubMed ID: 14715537
[TBL] [Abstract][Full Text] [Related]
18. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
[TBL] [Abstract][Full Text] [Related]
19. Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine.
Borrow R; Richmond P; Kaczmarski EB; Iverson A; Martin SL; Findlow J; Acuna M; Longworth E; O'Connor R; Paul J; Miller E
FEMS Immunol Med Microbiol; 2000 May; 28(1):79-85. PubMed ID: 10767611
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence.
Stoof SP; van Ravenhorst MB; van Rooijen DM; de Voer RM; van der Klis FRM; Boland GJ; Sanders EAM; Berbers GAM; Teunis PF
Clin Vaccine Immunol; 2017 Feb; 24(2):. PubMed ID: 27881489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]